Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Supply Tirzepatide 99% White powder High Quality tirzepatide
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - large image1
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - image1
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - image2
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - image3
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - image4
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - image5
Supply Tirzepatide 99% White powder High Quality tirzepatide buy - image6

Supply Tirzepatide 99% White powder High Quality tirzepatide

2101 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Xian

Brand:

Fulecare

Packaging:

Plastic bag

Price valid (until):

2026-05-20

Company Type:
Trader
Location:
China
Payment Terms:
L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
335 days
Qualification:
Main Products:

Slu-pp-332,BAM 15

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    Cas No. 2023788-19-2 SDF

    Formula C225H348N48O68 M.Wt 4813.45

    Solubility Soluble in DMSO Storage Store at -20°C

    General tips For obtaining a higher solubility, please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

    Stock solution can be stored below -20℃ for several months.

    Shipping Condition Secure Appearance: Powder Purity: >99% (or refer to the Certificate of Analysis)

    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

    Solubility: To be determined Shelf Life: >2 years if stored properly

    Drug Formulation: To be determined

    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

    Category Peptides Purpose Weight Loss
    Bottle Color Transparent MOQ 10 Vials
    Purity 99% Storage Dry Cool Sealed Container
    Specification 5mg, 10mg, 15mg, 20mg, 30mg, etc Form Lyophilized Powder(Freeze-Dried Powder)
    Origin China Production Capacity 40000vials/Week
    Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 1 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 2 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 3 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 4 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 5 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 6 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 7 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 8 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 9 Shop Supply Tirzepatide 99% White powder High Quality tirzepatide-Detailed Image 10
    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Slu-pp-332,BAM 15

    Location:

    No. 11608, 16th Floor, Unit 1, Building 1, West of Zhangba Liu Road, South Third Ring Road, High tech Zone, Xi'an City, Shaanxi Province

    Payment Terms:

    L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    335 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    2101 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.